Mucin production and hydration responses to mucopurulent materials in normal versus cystic fibrosis airway epithelia

American Journal of Respiratory and Critical Care Medicine

Volumn 197, Issue 4, 2018, Pages 481-491

  Abdullah, Lubna H ^a   Coakley, Raymond ^a   Webster, Megan J ^a   Zhu, Yunxiang ^a   Tarran, Robert ^a   Radicioni, Giorgia ^a   Kesimer, Mehmet ^a   Boucher, Richard C ^a   Davis, C William ^a   Ribeiro, Carla M P ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Airway hydration; Airway inflammation; Airway mucins; Cystic fibrosis

Indexed keywords

CATHEPSIN G; GELATINASE B; LEUKOCYTE ELASTASE; MUCIN; MUCIN 5AC; MUCIN 5B; NEUTROPHIL COLLAGENASE;

ARTICLE; BRONCHUS EPITHELIUM; CYSTIC FIBROSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOCYTOSIS; HUMAN; HUMAN CELL; HYDRATION; ION TRANSPORT; MUCUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; RESPIRATORY EPITHELIUM; UPREGULATION; BIOSYNTHESIS; CELL CULTURE TECHNIQUE; COMPARATIVE STUDY; EPITHELIUM; FLUID THERAPY; LUNG; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION; RESPIRATORY MUCOSA;

CELL CULTURE TECHNIQUES; CYSTIC FIBROSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; FLUID THERAPY; HUMANS; LUNG; MUCINS; POLYMERASE CHAIN REACTION; RESPIRATORY MUCOSA;

EID: 85045190351     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201706-1139OC     Document Type: Article

References (49)

1. Knowles MR, Boucher RC. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 2002; 109:571-577.
2. Kesimer M, Ehre C, Burns KA, Davis CW, Sheehan JK, Pickles RJ. Molecular organization of the mucins and glycocalyx underlying mucus transport over mucosal surfaces of the airways. Mucosal Immunol 2013; 6:379-392.
3. Holmén JM, Karlsson NG, Abdullah LH, Randell SH, Sheehan JK, Hansson GC, et al. Mucins and their O-glycans from human bronchial epithelial cell cultures. Am J Physiol Lung Cell Mol Physiol 2004; 287: L824-L834.
4. Abdullah LH, Davis SW, Burch L, Yamauchi M, Randell SH, Nettesheim P, et al. P2u purinoceptor regulation of mucin secretion in SPOC1 cells, a goblet cell line from the airways. Biochem J 1996; 316: 943-951.
5. Rose MC, Voynow JA. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 2006; 86:245-278.
6. Roy MG, Livraghi-Butrico A, Fletcher AA, McElwee MM, Evans SE, Boerner RM, et al. Muc5b is required for airway defence. Nature 2014; 505:412-416.
7. Perez-Vilar J, Boucher RC. Reevaluating gel-forming mucins' roles in cystic fibrosis lung disease. Free Radic Biol Med 2004; 37:1564-1577.
8. Anderson WH, Coakley RD, Button B, Henderson AG, Zeman KL, Alexis NE, et al. The relationship of mucus concentration (hydration) to mucus osmotic pressure and transport in chronic bronchitis. Am J Respir Crit Care Med 2015; 192:182-190.
9. Kim V, Oros M, Durra H, Kelsen S, Aksoy M, Cornwell WD, et al. Chronic bronchitis and current smoking are associated with more goblet cells in moderate to severe COPD and smokers without airflow obstruction. PLoS One 2015; 10:e0116108.
10. Voynow JA, Gendler SJ, Rose MC. Regulation of mucin genes in chronic inflammatory airway diseases. Am J Respir Cell Mol Biol 2006; 34:661-665.
11. Ribeiro CM, Paradiso AM, Schwab U, Perez-Vilar J, Jones L, O'neal W, et al. Chronic airway infection/inflammation induces a Ca2 + i-dependent hyperinflammatory response in human cystic fibrosis airway epithelia. J Biol Chem 2005; 280:17798-17806.
12. Martino MEB, Olsen JC, Fulcher NB, Wolfgang MC, O'Neal WK, Ribeiro CMP Airway epithelial inflammation-induced endoplasmic reticulum Ca2 + store expansion is mediated by X-box binding protein-1. J Biol Chem 2009; 284:14904-14913.
13. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995; 152:2111-2118.
14. Esther CRJ Jr, Alexis NE, Clas ML, Lazarowski ER, Donaldson SH, Ribeiro CM, et al. Extracellular purines are biomarkers of neutrophilic airway inflammation. Eur Respir J 2008; 31:949-956.
15. Kesimer M, Kirkham S, Pickles RJ, Henderson AG, Alexis NE, Demaria G, et al. Tracheobronchial air-liquid interface cell culture: a model for innate mucosal defense of the upper airways? Am J Physiol Lung Cell Mol Physiol 2009; 296:L92-L100.
16. Abdullah LH, Wolber C, Kesimer M, Sheehan JK, Davis CW. Studying mucin secretion from human bronchial epithelial cell primary cultures. Methods Mol Biol 2012; 842:259-277.
17. Zhu Y, Abdullah LH, Doyle SP, Nguyen K, Ribeiro CM, Vasquez PA, et al. Baseline goblet cell mucin secretion in the airways exceeds stimulated secretion over extended time periods, and is sensitive to shear stress and intracellular mucin stores. PLoS One 2015; 10: e0127267.
18. Sheehan JK, Boot-Handford RP, Chantler E, Carlstedt I, Thornton DJ. Evidence for shared epitopes within the 'naked' protein domains of human mucus glycoproteins. A study performed by using polyclonal antibodies and electron microscopy. Biochem J 1991; 274:293-296.
19. Thornton DJ, Carlstedt I, Howard M, Devine PL, Price MR, Sheehan JK. Respiratory mucins: identification of core proteins and glycoforms. Biochem J 1996; 316:967-975.
20. Rousseau K, Wickstrom C, Whitehouse DB, Carlstedt I, Swallow DM. New monoclonal antibodies to non-glycosylated domains of the secreted mucins MUC5B and MUC7. Hybrid Hybridomics 2003; 22:293-299.
21. Kirkham S, Sheehan JK, Knight D, Richardson PS, Thornton DJ. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. Biochem J 2002; 361:537-546.
22. Zhu Y, Ehre C, Abdullah LH, Sheehan JK, Roy M, Evans CM, et al. Munc13-2-/- baseline secretion defect reveals source of oligomeric mucins in mouse airways. J Physiol 2008; 586:1977-1992.
23. Sagel SD, Chmiel JF, Konstan MW. Sputum biomarkers of inflammation in cystic fibrosis lung disease. Proc Am Thorac Soc 2007; 4:406-417.
24. Tarran R, Loewen ME, Paradiso AM, Olsen JC, Gray MA, Argent BE, et al. Regulation of murine airway surface liquid volume by CFTR and Ca21-activated Clconductances. J Gen Physiol 2002; 120: 407-418.
25. Tarran R, Trout L, Donaldson SH, Boucher RC. Soluble mediators, not cilia, determine airway surface liquid volume in normal and cystic fibrosis superficial airway epithelia. J Gen Physiol 2006; 127: 591-604.
26. Henderson AG, Ehre C, Button B, Abdullah LH, Cai LH, Leigh MW, et al. Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure. J Clin Invest 2014; 124: 3047-3060.
27. Rogers DF Airway goblet cells: responsive and adaptable front-line defenders. Eur Respir J 1994; 7:1690-1706.
28. Voynow JA, Fischer BM, Zheng S. Proteases and cystic fibrosis. Int J Biochem Cell Biol 2008; 40:1238-1245.
29. Ratjen F, Hartog CM, Paul K, Wermelt J, Braun J. Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alpha. Thorax 2002; 57: 930-934.
30. Gaggar A, Li Y, Weathington N, Winkler M, Kong M, Jackson P, et al. Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients. Am J Physiol Lung Cell Mol Physiol 2007; 293:L96-L104.
31. Yamada N, Nishida Y, Yokoyama S, Tsutsumida H, Houjou I, Kitamoto S, et al. Expression of MUC5AC, an early marker of pancreatobiliary cancer, is regulated by DNA methylation in the distal promoter region in cancer cells. J Hepatobiliary Pancreat Sci 2010; 17: 844-854.
32. Mall M, Grubb BR, Harkema JR, O'Neal WK, Boucher RC. Increased airway epithelial Na1 absorption produces cystic fibrosis-like lung disease in mice. Nat Med 2004; 10:487-493.
33. Kesimer M, Ford AA, Ceppe A, Radicioni G, Cao R, Davis WC, et al. Airway mucin concentration as a marker of chronic bronchitis. N Engl J Med 2017; 377:911-922.
34. Klinger JD, Tandler B, Liedtke CM, Boat TF. Proteinases of Pseudomonas aeruginosa evoke mucin release by tracheal epithelium. J Clin Invest 1984; 74:1669-1678.
35. Lundgren JD, Rieves RD, Mullol J, Logun C, Shelhamer JH. The effect of neutrophil protenase enzymes on the release of mucus from feline and human airway cultures. Respir Med 1994; 88:511-518.
36. Liu Z, Zhou X, Shapiro SD, Shipley JM, Twining SS, Diaz LA, et al. The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell 2000; 102:647-655.
37. Gadek JE, Klein HG, Holland PV, Crystal RG. Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects. J Clin Invest 1981; 68:1158-1165.
38. Rossi AH, Salmon WC, Chua M, Davis CW. Calcium signaling in human airway goblet cells following purinergic activation. Am J Physiol Lung Cell Mol Physiol 2007; 292:L92-L98.
39. Paradiso AM, Ribeiro CMP, Boucher RC. Polarized signaling via purinoceptors in normal and cystic fibrosis airway epithelia. J Gen Physiol 2001; 117:53-67.
40. Fischer BM, Rochelle LG, Voynow JA, Akley NJ, Adler KB. Tumor necrosis factor-alpha stimulates mucin secretion and cyclic GMP production by guinea pig tracheal epithelial cells in vitro. Am J Respir Cell Mol Biol 1999; 20:413-422.
41. Okada SF, Ribeiro CM, Sesma JI, Seminario-Vidal L, Abdullah LH, van Heusden C, et al. Inflammation promotes airway epithelial ATP release via calcium-dependent vesicular pathways. Am J Respir Cell Mol Biol 2013; 49:814-820.
42. Abdullah LH, Davis CW. Regulation of airway goblet cell mucin secretion by tyrosine phosphorylation signaling pathways. Am J Physiol Lung Cell Mol Physiol 2007; 293:L591-L599.
43. Henke MO, John G, Rheineck C, Chillappagari S, Naehrlich L, Rubin BK. Serine proteases degrade airway mucins in cystic fibrosis. Infect Immun 2011; 79:3438-3444.
44. Fischer BM, Voynow JA. Neutrophil elastase induces MUC5AC gene expression in airway epithelium via a pathway involving reactive oxygen species. Am J Respir Cell Mol Biol 2002; 26: 447-452.
45. Koo JS, Kim YD, Jetten AM, Belloni P, Nettesheim P. Overexpression of mucin genes induced by interleukin-1 beta, tumor necrosis factor-alpha, lipopolysaccharide, and neutrophil elastase is inhibited by a retinoic acid receptor alpha antagonist. Exp Lung Res 2002; 28: 315-332.
46. Gray T, Nettesheim P, Loftin C, Koo JS, Bonner J, Peddada S, et al. Interleukin-1beta-induced mucin production in human airway epithelium is mediated by cyclooxygenase-2, prostaglandin E2 receptors, and cyclic AMP-protein kinase A signaling. Mol Pharmacol 2004; 66:337-346.
47. Button B, Anderson WH, Boucher RC. Mucus hyperconcentration as a unifying aspect of the chronic bronchitic phenotype. Ann Am Thorac Soc 2016; 13:S156-S162.
48. Matthews LW, Spector S, Lemm J, Potter JL. Studies on pulmonary secretions. I. The over-all chemical composition of pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy. Am Rev Respir Dis 1963; 88:199-204.
49. Redding GJ, Kishioka C, Martinez P, Rubin BK. Physical and transport properties of sputum from children with idiopathic bronchiectasis. Chest 2008; 134:1129-1134.